POLYNUCLEOTIDE ASSOCIATED WITH THE BO OR BOR SYNDROME, ITS CORRESPONDING POLYPEPTIDE AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

• Main Authors: WEIL, DOMINIQUE, ABDELHAK, SONIA, COMPAIN, SYLVIE, VASILIKI, KALATZIS, VINCENT, CHRISTOPHE, PETIT, CHRISTINE
• Format: Patent
• Language: English; French
• Published: 30.07.1998
• Edition: 6
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE; TESTING; VINEGAR; WINE

This invention concerns a polynucleotide which is selected from the group consisting of: (a) a polynucleotide comprising at least 8 consecutive nucleotides of SEQ ID No. 1; (b) a polynucleotide differing from the polynucleotide defined in (a) by mutation, insertion, deletion of substitution of one or more bases; (c) a polynucleotide, the sequence of which is complementary to the sequence of anyone of polynucleotides defined in (a) and (b); (d) a polynucleotide which hybridizes specifically with anyone of the polynucleotides defined in (a), (b) or (c). L'invention concerne un polynucléotide choisi dans le groupe constitué par: (a) un polynucléotide comprenant au moins 8 nucléotides consécutifs de la SEQ ID No. 1, (b) un polynucléotide différant de celui défini en (a) par suite d'une mutation, d'une insertion, d'une délétion ou d'une substitution d'une ou de plusieurs bases, (c) un polynucléotide dont la séquence est complémentaire de la séquence de l'un quelconque des polynucléotides défini en (a) et en (b), et (d) un polynucléotide s'hybridant de façon spécifique avec l'un quelconque des polynucléotides définis en (a), (b) ou (c).